Mutagenesis on a complex mouse genetic background by site-specific nucleases

• Published in: Transgenic research
• Main Authors: Davies, Benjamin, Trelfa, Lucy, Rashbrook, Victoria S, Drydale, Edward, Martin, Rachel, Bai, Boyan, Golebka, Jedrzej, Biggs, Daniel Stephen, Channon, Keith M, Bhattacharya, Shoumo, Douglas, Gillian
• Format: Journal Article
• Language: English
• Published: Netherlands 01-08-2024
• Subjects: Regression; 3Rs; Abcg1; Atherosclerosis; Site directed mutagenesis
• DOI: 10.1007/s11248-024-00399-5
• EISSN: 1573-9368
• ISSN: 0962-8819; 1573-9368

Mouse models with complex genetic backgrounds are increasingly used in preclinical research to accurately model human disease and to enable temporal and cell-specific evaluation of genetic manipulations. Backcrossing mice onto these complex genetic backgrounds takes time and leads to significant wastage of animals. In this study, we aimed to evaluate whether site-specific nucleases could be used to generate additional genetic mutations in a complex genetic background, using the REVERSA mouse model of atherosclerosis, a model harbouring four genetically altered alleles. The model is comprised of a functional null mutation in the Ldlr gene in combination with a ApoB100 allele, which, after high-fat diet, leads to the rapid development of atherosclerosis. The regression of the pathology is achieved by inducible knock-out of the Mttp gene. Here we report an investigation to establish if microinjection of site-specific nucleases directly into zygotes prepared from the REVERSA could be used to investigate the role of the ATP binding cassette transporter G1 (ABCG1) in atherosclerosis regression. We show that using this approach we could successfully generate two independent knockout lines on the REVERSA background, both of which exhibited the expected phenotype of a significant reduction in cholesterol efflux to HDL in bone marrow-derived macrophages. However, loss of Abcg1 did not impact atherosclerosis regression in either the aortic root or in aortic arch, demonstrating no important role for this transporter subtype. We have demonstrated that site-specific nucleases can be used to create genetic modifications directly onto complex disease backgrounds and can be used to explore gene function without the need for laborious backcrossing of independent strains, conveying a significant 3Rs advantage.